Chelsea Kotch

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Expert review of clinical immunology

Journal of neuro-oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Chelsea Kotch, Kristina Wagner, J Harris Broad, Eva Dombi, Jane E Minturn, Peter Phillips, Katherine A Smith, Yimei Li, Ian N Jacobs, Lisa M Elden, Michael J Fisher, Jean Belasco
Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study. Cancers 15 (9) (2023)
Chelsea Kotch, Kristina Wagner, J Harris Broad, Eva Dombi, Jane E Minturn, Peter Phillips, Katherine A Smith, Yimei Li, Ian N Jacobs, Lisa M Elden, Michael J Fisher, Jean Belasco
Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study. Cancers 15 (9) (2023)
Chelsea Kotch, Stephanie J Si, Kavita Desai, Philippe Caminada, Francesco Maria Lo Russo, Yimei Li, Grant T Liu, Robert A Avery, Michael J Fisher
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis. Journal of neuro-oncology (2023)
Chelsea Kotch, Robert Avery, Kelly D Getz, Eric Bouffet, Peter de Blank, Robert Listernick, David H Gutmann, Miriam Bornhorst, Cynthia Campen, Grant T Liu, Richard Aplenc, Yimei Li, Michael J Fisher
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1. Neuro-oncology 24 (8) (2022)
Chelsea Kotch, David Barrett, David T Teachey
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome. Expert review of clinical immunology 15 (8) (2019)